Skip to content

Clinical trials

Phase 2/3 trials in Saudi Arabia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Country / region: Saudi Arabia Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20102
20121
20131
20141
20162
20172
20182
20194
20205
20224
20233
20241
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting10
Active, not recruiting4
Unknown status4
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
King Saud University4
Beni-Suef University3
King Abdullah International Medical Research Center3
King Abdullah Medical City2
Mansoura University2
Saudi German Hospital - Madinah2
Agios Pharmaceuticals, Inc.1
Alexion Pharmaceuticals, Inc.1
Biogen1
Crinetics Pharmaceuticals Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Sickle Cell3
COVID-193
Polycystic Ovary Syndrome2
Premature Birth2
Sepsis2
Adrenal Hyperplasia, Congenital1
Autoimmune Diseases1
Bone Diseases1
Breast Neoplasms1
Bronchopulmonary Dysplasia1

Trials

Showing 76 to 32 of 32. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.